All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-33093566

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	33093566	D116A	IN	gag-pol	HIV Infections	D G R	View
2	33093566	E152A	IN	gag-pol	HIV Infections	D G R	View
3	33093566	E152E	IN	gag-pol	HIV Infections	D G R	View
4	33093566	G73S	PR	gag-pol	HIV Infections	D G R	View
5	33093566	G73T	PR	gag-pol	HIV Infections	D G R	View
6	33093566	I47V	PR	gag-pol	HIV Infections	D G R	View
7	33093566	I54L	PR	gag-pol	HIV Infections	D G R	View
8	33093566	I84V	PR	gag-pol	HIV Infections	D G R	View
9	33093566	K20T	PR	gag-pol	HIV Infections	D G R	View
10	33093566	K43T	PR	gag-pol	HIV Infections	D G R	View
11	33093566	L10F	PR	gag-pol	HIV Infections	D G R	View
12	33093566	L33F	PR	gag-pol	HIV Infections	D G R	View
13	33093566	L89V	PR	gag-pol	HIV Infections	D G R	View
14	33093566	L90M	PR	gag-pol	HIV Infections	D G R	View
15	33093566	M46I	PR	gag-pol	HIV Infections	D G R	View
16	33093566	Q58E	PR	gag-pol	HIV Infections	D G R	View
17	33093566	V32I	PR	gag-pol	HIV Infections	D G R	View
18	33093566	V82T	PR	gag-pol	HIV Infections	D G R	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.